Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1968 Oct 31;128(5):1081–1098. doi: 10.1084/jem.128.5.1081

PERSISTENCE OF STREPTOCOCCAL GROUP A ANTIBODY IN PATIENTS WITH RHEUMATIC VALVULAR DISEASE

Burton A Dudding 1, Elia M Ayoub 1
PMCID: PMC2138567  PMID: 5682941

Abstract

Antibody levels to streptococcal Group A and A-variant carbohydrates were determined using a radioactive immune precipitation technique on patients with rheumatic fever, with and without valvular disease, on patients with post-streptococcal acute glomerulonephritis, and on age-matched controls. During the acute phase of the above illness, the means of the antibody levels to both carbohydrate antigens were equally elevated and were significantly higher than the normal controls. When Group A antibody levels were determined on sera obtained at intervals of 5–12 months and 1–5 yr after the acute illness) it was found that the antibody levels declined within the normal range at the 5–12 month interval in patients with glomerulonephritis as well as in patients with rheumatic fever in whom no valvular involvement had complicated the disease, i.e., patients with pure Sydenham's chorea. However, in patients with rheumatic valvulitis, who had been on penicillin prophylaxis after the last acute episode, the A antibody level showed little decline from the level obtained during the acute illness. The elevated antibody level in patients with rheumatic valvulitis, including patients with Sydenham's chorea with valvulitis, persisted for periods of at least 1 yr and up to 20 yr after the last acute attack. The pattern of the decline of the antibody levels to the A-variant carbohydrate as well as of the antibody titers to the other streptococcal antigens tested, ASO and anti-DNase B, was similar in all patients studied regardless of the presence of valvular disease. These findings suggest that prolonged persistence of the Group A antibody is a phenomenon peculiar to patients with rheumatic valvular disease. Whether this persistence is involved in the pathogenesis or is an outcome of the valvular disease remains to be determined.

Full Text

The Full Text of this article is available as a PDF (948.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayoub E. M., McCarty M. Intraphagocytic beta-N-acetylglucosaminidase. Properties of the enzyme and its activity on group A streptococcal carbohydrate in comparison with a soil bacillus enzyme. J Exp Med. 1968 Apr 1;127(4):833–851. doi: 10.1084/jem.127.4.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ayoub E. M., Wannamaker L. W. Streptococcal antibody titers in Sydenham's chorea. Pediatrics. 1966 Dec;38(6):946–956. [PubMed] [Google Scholar]
  3. Edwards E. A. Protocol for micro antistreptolysin O determinations. J Bacteriol. 1964 May;87(5):1254–1255. doi: 10.1128/jb.87.5.1254-1255.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FARR R. S. A quantitative immunochemical measure of the primary interaction between I BSA and antibody. J Infect Dis. 1958 Nov-Dec;103(3):239–262. doi: 10.1093/infdis/103.3.239. [DOI] [PubMed] [Google Scholar]
  5. HALPERN B., GOLDSTEIN I. UTILISATION DU POLYOSIDE STREPTOCOCCIQUE MARQU'E AU 14C POUR LA D'ETERMINATION DE FAIBLES QUANTIT'ES D'ANTICORPS SP'ECIFIQUES DANS DES S'ERUMS EXP'ERIMENTAUX ET HUMAINS. Rev Immunol Ther Antimicrob. 1964 Jul-Sep;28:193–204. [PubMed] [Google Scholar]
  6. HEYMANN H., MANNIELLO J. M., BARKULIS S. S. Structure of streptococcal cell walls. I. Methylation study of C-polysaccharide. J Biol Chem. 1963 Feb;238:502–509. [PubMed] [Google Scholar]
  7. KAPLAN M. H., SVEC K. H. IMMUNOLOGIC RELATION OF STREPTOCOCCAL AND TISSUE ANTIGENS. III. PRESENCE IN HUMAN SERA OF STREPTOCOCCAL ANTIBODY CROSS-REACTIVE WITH HEART TISSUE. ASSOCIATION WITH STREPTOCOCCAL INFECTION, RHEUMATIC FEVER, AND GLOMERULONEPHRITIS. J Exp Med. 1964 Apr 1;119:651–666. doi: 10.1084/jem.119.4.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. KARAKAWA W. W., OSTERLAND C. K., KRAUSE R. DETECTION OF STREPTOCOCCAL GROUP-SPECIFIC ANTIBODIES IN HUMAN SERA. J Exp Med. 1965 Aug 1;122:195–205. doi: 10.1084/jem.122.2.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. KRAUSE R. M., MCCARTY M. Studies on the chemical structure of the streptococcal cell wall. I. The identification of a mucopeptide in the cell walls of groups A and A-variant streptococci. J Exp Med. 1961 Jul 1;114:127–140. doi: 10.1084/jem.114.1.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Karakawa W. W., Lackland H., Krause R. M. The production of streptococcal group-specific antibodies in rabbits. I. The identification of groups A and A-variant agglutinins in group A antisera. J Immunol. 1966 Feb;96(2):204–209. [PubMed] [Google Scholar]
  11. LANCEFIELD R. C. Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med. 1959 Aug 1;110(2):271–292. doi: 10.1084/jem.110.2.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Murray R. F., Jr, Robinson J. C., Dublin T. D., Pitt E. L., Visnich S. Haptoglobins and rheumatic fever. Br Med J. 1966 Mar 26;1(5490):762–765. doi: 10.1136/bmj.1.5490.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nelson J., Ayoub E. M., Wannamaker L. W. Streptococcal anti-desoxyribonuclease B: microtechnique determination. J Lab Clin Med. 1968 May;71(5):867–873. [PubMed] [Google Scholar]
  14. RAMMELKAMP C. H., Jr, STOLZER B. L. The latent period before the onset of acute rheumatic fever. Yale J Biol Med. 1961 Dec;34:386–398. [PMC free article] [PubMed] [Google Scholar]
  15. RONDLE C. J., MORGAN W. T. The determination of glucosamine and galactosamine. Biochem J. 1955 Dec;61(4):586–589. doi: 10.1042/bj0610586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. SCHMIDT W. C., MOORE D. J. THE DETERMINATION OF ANTIBODY TO GROUP A STREPTOCOCCAL POLYSACCHARIDE IN HUMAN SERA BY HEMAGGLUTINATION. J Exp Med. 1965 May 1;121:793–806. doi: 10.1084/jem.121.5.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schwab J. H., Ohanian S. H. Degradation of streptococcal cell wall antigens in vivo. J Bacteriol. 1967 Nov;94(5):1346–1352. doi: 10.1128/jb.94.5.1346-1352.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Spagnuolo M., Taranta A. Rheumatic fever in siblings. Similarity of its clinical manifestations. N Engl J Med. 1968 Jan 25;278(4):183–188. doi: 10.1056/NEJM196801252780403. [DOI] [PubMed] [Google Scholar]
  19. TARANTA A., STOLLERMAN G. H. The relationship of Sydenham's chorea to infection with group A streptococci. Am J Med. 1956 Feb;20(2):170–175. doi: 10.1016/0002-9343(56)90186-3. [DOI] [PubMed] [Google Scholar]
  20. WILSON A. T., WILEY G. G. THE CELLULAR ANTIGENS OF GROUP A STREPTOCOCCI; IMMUNOELECTROPHORETIC STUDIES OF THE C, M, T, PGP, E4, F, AND E ANTIGENS OF SEROTYPE 17 STREPTOCOCCI. J Exp Med. 1963 Oct 1;118:527–556. doi: 10.1084/jem.118.4.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zabriskie J. B., Freimer E. H. An immunological relationship between the group. A streptococcus and mammalian muscle. J Exp Med. 1966 Oct 1;124(4):661–678. doi: 10.1084/jem.124.4.661. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES